Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: AB2 Bio, Aerie, Agex, Alterity, Amerimmune, Augmenta Bioworks, Bioinvent International, Bioprojet, Casi, Checkpoint, China Grand Pharmaceutical and Healthcare, Citrine Medicine, Cstone, Daewoong, Dr. Reddy’s Laboratories, Emulate, Entos, Fusion Antibodies, Genequantum Healthcare, Glaxosmithkline, Histogen, Immutep, Imstem, Innovation, Legochem, Moderna, Moleculin, Mymetics, Novartis, Novavax, Samsung Bioepis, Samsung Biologics, Sanofi, Santen, Sareum, SK, Sorrento, Spartina, Takeda, Telix, TFF, Vaxil Bio, Wuxi Biologics.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Biolytical Laboratories, DNA Genotek, Pari Pharma, Salvia Bioelectronics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alveo Technologies, Biocartis Group, Coloplast, Decision Diagnostics, DJO Global, Endpoint Health, Geneprodx, Hutchinson Technology, Joline, Mir Scientific, Morton Comprehensive Health Services, Motus GI, Nine Continents Medical, Novarad, Ossdsign, Oxford Gene Technology, Remark Holdings, Resonetics, Sirakoss, Stryker, Wright Medical Group.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunovia, Seaspine, Strata Skin Sciences.

Med-tech firms raising money in public or private financings, including: Fountain Healthcare Partners, Kyowa Kirin, Massive Bio, Nurami Medical.

New hires and promotions in the med-tech industry, including: Aethlon, American Injectables, Fast Biomedical, Inspire MD.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biomarin, Chemocentryx, Emmaus, Engene, Enlivex, Galapagos, Gensight, Gilead, Nanomab, Vifor Fresenius.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioasis, Calliditas, CEPI, Checkpoint, Clover, Genkyotex, Hoth, Humanigen, Immunoprecise, Inventiva, KPM, Minoryx, Sichuan Clover, Telcon RF, TLC, Xoma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Adial, Aptevo, Aurinia, Biogen, BMS, Celltrion, Concert, Edesa, GW, Horizon, Karyopharm, Lilly, Prometic.

Biopharmas raising money in public or private financings, including: Aquestive, Cancer Genetics, Forte, Fountain Healthcare, Inhibikase, Jiya, Massive Bio, Quantum Genomics, Scholar Rock, Ultragenyx.